NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 56 filers reported holding NUVALENT INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $384,904 | -83.9% | 8,380 | -85.3% | 0.00% | -100.0% |
Q2 2023 | $2,397,316 | -61.4% | 56,916 | -76.1% | 0.00% | -75.0% |
Q1 2023 | $6,215,353 | -14.2% | 237,954 | -2.2% | 0.00% | -20.0% |
Q4 2022 | $7,244,033 | -6.6% | 243,415 | -69.5% | 0.01% | -16.7% |
Q3 2022 | $7,752,745 | -54.2% | 797,312 | -36.1% | 0.01% | -50.0% |
Q2 2022 | $16,926,000 | -8.9% | 1,247,165 | -6.7% | 0.01% | +33.3% |
Q1 2022 | $18,577,000 | -28.9% | 1,337,425 | -5.7% | 0.01% | -18.2% |
Q4 2021 | $26,144,000 | -13.4% | 1,418,047 | -0.7% | 0.01% | -15.4% |
Q3 2021 | $30,174,000 | – | 1,427,976 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $436,140,000 | 8.51% |
Fairmount Funds Management LLC | 914,614 | $20,625,000 | 7.50% |
Bain Capital Life Sciences Investors, LLC | 3,428,014 | $77,302,000 | 4.80% |
VR Adviser, LLC | 803,951 | $18,129,000 | 2.33% |
Boxer Capital, LLC | 1,210,192 | $27,290,000 | 0.95% |
BVF INC/IL | 448,512 | $10,114,000 | 0.40% |
Avoro Capital Advisors LLC | 1,257,671 | $22,288,000 | 0.35% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,052,394 | $23,731,000 | 0.28% |
Perceptive Advisors | 750,000 | $16,913,000 | 0.25% |
Logos Global Management LP | 134,650 | $2,733,000 | 0.20% |